Novel diagnostic markers to evaluate gut dysbiosis in patients with sepsis

Novel diagnostic markers to evaluate gut dysbiosis in patients with sepsis - Novel diagnostic markers to evaluate gut dysbiosis in patients with sepsis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048780

Enrollment

100

Registered

2022-08-29

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with sepsis using Sepsis-3 Patients newly admitted to the ICU of Chiba University Hospital and expected to require intensive care for more than 48 hours

Exclusion criteria

Exclusion criteria: Patients with inflammatory bowel disease Patients with diarrhea prior to ICU admission Patients who have received multiple antimicrobial agents for a long period of time prior to ICU admission Patients who are judged by the principal investigator to be inappropriate as study subjects

Design outcomes

Primary

Measure	Time frame
Accuracy of diagnostic markers relating to gut dysbiosis	—

Countries

Japan

Contacts

Public ContactTakehiko Oami

Chiba University Hospital Emergency and Critical Care Medicine

seveneleven711thanks39@msn.com4042227171

Outcome results